Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)
Determination if Pharmacologic Blockade of Androgen Action Decreases Renal Clearance of D-Chiro-Inositol (DCI), Increases the Circulating Concentration of DCI, and Enhances Insulin-Stimulated Release of the D-chiro-inositol-containing Inositolphosphoglycan (DCI-IPG) Mediator in Obese Women With Polycystic Ovary Syndrome (PCOS)
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Terminated
Lack of recruitment
Other terminated trials from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Other Polycystic Ovary Syndrome trials with similar outcome
Listed as NCT00729560, this NA trial focuses on Polycystic Ovary Syndrome and remains terminated or withdrawn. Sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Jul 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Virginia Commonwealth University
For direct contact, visit the study record on ClinicalTrials.gov .